Lung Cancer
Lung cancer is the second tumor is more prevalent in the world. In indonesia alone, 20,000 cases are diagnosed annually, and mortality is the highest of all cancers.
So far the data are very encouraging: almost three quarters of patients the detection comes at later stages. For this reason, it is necessary to go on trial. The Association of People Affected by Lung Cancer (AEACaP) claims that are in place screening tests to reduce this type of cancer.
Attention to symptoms
One way to tackle cancer, quickly, is visiting the doctor or specialist as soon as symptoms appear. What are these signs? Some of the most important are summarized as:
- Persistent cough.
- Coughing up blood.
- Chest pain.
- Loss of breath.
- Hoarseness.
- Repeated chest infections.
- Inflammation in the chest or face.
- Constipation or diarrhea.
- Need to sleep sitting up. The snuff, the principal cause
In Spain, specifically, smoking is responsible for most of the tumors. Bernard Caspar AEACaP president, said that “in Spain, snuff consumption is responsible for about 80% of deaths from lung cancer and, therefore, from our association, we want the awareness of its harmful effects start from soon. The best thing is that children from going to school, aware of the evils of smoking.
Another aspect is that although in 2010 it will ban smoking in all enclosed spaces, the recent Omnibus Press allows establishments to sell snuff. According to Gaspar “is to step back in prevention, since it will further facilitate the access of minors to snuff for the increasing number of outlets.
To make matters worse, the snuff is responsible for 90% of bronchitis and 30% of coronary heart disease. According to Ministry of Health and Social Policy, smoking is linked to 10 other cancers (lung, esophagus, bladder, oral cavity and larynx are most common) and is the main cause of half of cardiovascular disease.
Therapeutic Innovation
The clinical and therapeutic advances, coupled with support to patients and concerned with raising awareness on prevention and early diagnosis are decreasing the scope of this cancer.
The president of the AEACaP notes that “it now requires that both the society at large and government, to realize the importance of the work carried out by institutions engaged in cancer research. It is therefore essential that researchers feel the support and recognition they deserve. ”
Future research should focus on the task of definition of clinical criteria to identify individuals who have a greater chance of developing a tumor. Similarly, the application of new technologies in medical imaging and research of new molecules which may play a role in the onset of the disease, will be the new lines to help control lung cancer.